Alexandra Lavalley-Morelle, Ph.D.
Director, MIDD Consultant
Bio
- Joined Pharmetheus in 2024, actively working in client projects
- Expertise includes biostatistics, especially joint modeling of longitudinal and time-to-event data in therapeutic areas such as infectious diseases
- M.Sc. in Biostatistics (2020) from the National School of Statistics and Data Analysis, France, and Ph.D. in Biostatistics (2023) from Paris Cité University, France
Pharmetheus affiliated publications
Population pharmacokinetics and pharmacodynamics of depemokimab in people with asthma and chronic rhinosinusitis with nasal polypsImplementing a full random effects model (FREM) workflow in R using the saemix packageExposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfallsExposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfalls (Poster)Assessment of Phase 1 pharmacokinetic-pharmacodynamic predictions, based on Phase 3 clinical trials results. Depemokimab pharmacokinetics and response in blood eosinophil count reduction for asthma and chronic rhinosinusitis with nasal polyps patients